NEW YORK (GenomeWeb News) – A bill was introduced into the US Senate yesterday that would make it possible for labs offering genetic and pharmacogenomic tests to bill Medicare directly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.